Page last updated: 2024-08-23
paclitaxel and amg531
paclitaxel has been researched along with amg531 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Bondarenko, IN; Jagiello-Gruszfeld, A; Kellum, A; Messam, C; Mostafa Kamel, Y; Patwardhan, R | 1 |
Trials
1 trial(s) available for paclitaxel and amg531
| Article | Year |
|---|---|
A randomized, double-blind, placebo-controlled, dose ranging study to assess the efficacy and safety of eltrombopag in patients receiving carboplatin/paclitaxel for advanced solid tumors.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Benzoates; Carboplatin; Disease Progression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hydrazines; Male; Middle Aged; Neoplasms; Paclitaxel; Placebos; Platelet Count; Polypharmacy; Pyrazoles; Treatment Outcome; Young Adult | 2010 |